The publications on this site are part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Achillion Pharmaceuticals Inc. / See Company Profile

Acquisition / Alexion buys Achillion for $930mm in cash / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 17, 2019

Alliance / Janssen gets rights to Achillion's HCV assets; deal terminated / Strategic Transactions / Deal Date: May 1, 2015 / Update Date: Sep. 1, 2017

Financing / Achillion gets $225mm equity investment from JJDC / Strategic Transactions / Deal Date: May 1, 2015 / Publish Date: May 20, 2015

Alexion Pharmaceuticals Inc. / See Company Profile

Alliance / Alexion gets exclusive option to Stealth's elamipretide / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 25, 2019

Acquisition / Alexion buys Achillion for $930mm in cash / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 17, 2019

Alliance / Alexion gets Japanese rights to Eidos's AG10 / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 11, 2019

Innate Pharma SA / See Company Profile

Financing / Innate Pharma nets $73.5mm in initial public offering / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 25, 2019

Alliance / Innate licenses AZ's Lumoxiti / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 24, 2018

Alliance / AZ and MedImmune get exclusive rights from Innate; deal expanded / Strategic Transactions / Deal Date: Apr. 1, 2015 / Update Date: Oct. 1, 2018


Medical Devices

Email Alert | RSS Feed

Klox Technologies Inc. / See Company Profile

Acquisition / Klox acquires full ownership of FB Dermatology JV / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 17, 2019

Alliance / Klox and Leo team up again, forming a dermatology JV; Klox later acquires ownership / Strategic Transactions / Deal Date: Mar. 1, 2017 / Update Date: Oct. 1, 2019

Alliance / Leo Pharma takes stake in Klox, enters dermatology device market / Strategic Transactions / Deal Date: Jul. 1, 2014 / Update Date: Mar. 1, 2017

LeMaitre Vascular Inc. / See Company Profile

Alliance / LeMaitre buys Admedus' CardioCel and VascuCel patches / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 16, 2019

Acquisition / LeMaitre buys Applied Medical's vascular clot management biz / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Oct. 1, 2018

Alliance / LeMaitre buys ProCol vascular bioprosthesis from Hancock Jaffe / Strategic Transactions / Deal Date: Mar. 1, 2016 / Publish Date: Mar. 24, 2016


In Vitro Diagnostics

Email Alert | RSS Feed

Natera Inc. / See Company Profile

Financing / Public offering nets $188mm for Natera / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 22, 2019

Financing / Public offering nets Natera $108mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 22, 2019

Alliance / Natera to launch Signatera test in China on BGI's DNBseq NGS platform / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 12, 2019


Pharmaceuticals

Email Alert | RSS Feed

Zealand Pharma AS / See Company Profile

Acquisition / Zealand Pharma acquires fellow GI drug developer Encycle Therapeutics / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 23, 2019

Financing / Zealand Pharma gets DKK559.6mm via PIPE / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 9, 2019

Alliance / BI gets diabetes, obesity candidates from Zealand Pharma / Strategic Transactions / Deal Date: Jun. 1, 2011 / Update Date: Sep. 1, 2019

RedHill Biopharma Ltd. / See Company Profile

Alliance / RedHill gets US rights to Cosmo's Aemcolo GI drug / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 18, 2019

Financing / FOPO nets $18.8mm for RedHill / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Dec. 11, 2018

Financing / RedHill Biopharma nets $23.7mm through FOPO / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 10, 2018

Rhythm Pharmaceuticals Inc. / See Company Profile

Financing / Rhythm Pharma nets $162mm via FOPO / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 17, 2019

Financing / Rhythm nets $163.7mm via FOPO / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 22, 2018

Alliance / Rhythm takes rights to Takeda's Prader-Willi candidate / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 4, 2018

Biotechnology

Biotechnology

Email Alert | RSS Feed

Achillion Pharmaceuticals Inc. / See Company Profile

Acquisition / Alexion buys Achillion for $930mm in cash / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 17, 2019

Alliance / Janssen gets rights to Achillion's HCV assets; deal terminated / Strategic Transactions / Deal Date: May 1, 2015 / Update Date: Sep. 1, 2017

Financing / Achillion gets $225mm equity investment from JJDC / Strategic Transactions / Deal Date: May 1, 2015 / Publish Date: May 20, 2015

Alexion Pharmaceuticals Inc. / See Company Profile

Alliance / Alexion gets exclusive option to Stealth's elamipretide / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 25, 2019

Acquisition / Alexion buys Achillion for $930mm in cash / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 17, 2019

Alliance / Alexion gets Japanese rights to Eidos's AG10 / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 11, 2019

Innate Pharma SA / See Company Profile

Financing / Innate Pharma nets $73.5mm in initial public offering / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 25, 2019

Alliance / Innate licenses AZ's Lumoxiti / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 24, 2018

Alliance / AZ and MedImmune get exclusive rights from Innate; deal expanded / Strategic Transactions / Deal Date: Apr. 1, 2015 / Update Date: Oct. 1, 2018

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Klox Technologies Inc. / See Company Profile

Acquisition / Klox acquires full ownership of FB Dermatology JV / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 17, 2019

Alliance / Klox and Leo team up again, forming a dermatology JV; Klox later acquires ownership / Strategic Transactions / Deal Date: Mar. 1, 2017 / Update Date: Oct. 1, 2019

Alliance / Leo Pharma takes stake in Klox, enters dermatology device market / Strategic Transactions / Deal Date: Jul. 1, 2014 / Update Date: Mar. 1, 2017

LeMaitre Vascular Inc. / See Company Profile

Alliance / LeMaitre buys Admedus' CardioCel and VascuCel patches / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 16, 2019

Acquisition / LeMaitre buys Applied Medical's vascular clot management biz / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Oct. 1, 2018

Alliance / LeMaitre buys ProCol vascular bioprosthesis from Hancock Jaffe / Strategic Transactions / Deal Date: Mar. 1, 2016 / Publish Date: Mar. 24, 2016

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Natera Inc. / See Company Profile

Financing / Public offering nets $188mm for Natera / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 22, 2019

Financing / Public offering nets Natera $108mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 22, 2019

Alliance / Natera to launch Signatera test in China on BGI's DNBseq NGS platform / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 12, 2019

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Zealand Pharma AS / See Company Profile

Acquisition / Zealand Pharma acquires fellow GI drug developer Encycle Therapeutics / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 23, 2019

Financing / Zealand Pharma gets DKK559.6mm via PIPE / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 9, 2019

Alliance / BI gets diabetes, obesity candidates from Zealand Pharma / Strategic Transactions / Deal Date: Jun. 1, 2011 / Update Date: Sep. 1, 2019

RedHill Biopharma Ltd. / See Company Profile

Alliance / RedHill gets US rights to Cosmo's Aemcolo GI drug / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 18, 2019

Financing / FOPO nets $18.8mm for RedHill / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Dec. 11, 2018

Financing / RedHill Biopharma nets $23.7mm through FOPO / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 10, 2018

Rhythm Pharmaceuticals Inc. / See Company Profile

Financing / Rhythm Pharma nets $162mm via FOPO / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 17, 2019

Financing / Rhythm nets $163.7mm via FOPO / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 22, 2018

Alliance / Rhythm takes rights to Takeda's Prader-Willi candidate / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 4, 2018

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel